Literature DB >> 2904794

Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates.

J J Gilbert1, S J Kish, L J Chang, C Morito, K Shannak, O Hornykiewicz.   

Abstract

The neurochemical markers for the major neurotransmitter systems were measured in the brain of a patient who died with a dementia-parkinsonism-motor neuron disease (DPMN) syndrome complex. Moderate neuronal loss in the substantia nigra, spongiform changes in the frontal cortex, and moderate anterior horn cell loss throughout the spinal cord were observed. A severe nigrostriatal dopamine deficiency provides the basis for the observed parkinsonian features. The dementia is unexplained.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2904794     DOI： 10.1002/ana.410240518

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  J Mol Neurosci       Date:  2011-06-08       Impact factor: 3.444

2.  Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells.

Authors:  Akiko Yamamuro; Yasuhiro Yoshioka; Kiyokazu Ogita; Sadaaki Maeda
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

3.  Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

Authors:  I Ferrer; T Tuñón; M T Serrano; R Casas; S Alcántara; M J Zújar; R M Rivera
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

4.  HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells.

Authors:  Tomohiro Omura; Masaru Asari; Joe Yamamoto; Naoya Kamiyama; Kumiko Oka; Chisato Hoshina; Chikatoshi Maseda; Toshio Awaya; Yoshikazu Tasaki; Hiroshi Shiono; Keiko Shimizu; Kazuo Matsubara
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

Review 5.  Parkinsonism in motor neuron disease: case report and literature review.

Authors:  T L Williams; P J Shaw; J Lowe; D Bates; P G Ince
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.

Authors:  K C Wilhelmsen; T Lynch; E Pavlou; M Higgins; T G Nygaard
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

7.  Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex.

Authors:  I Ferrer; C Roig; A Espino; G Peiro; X Matias Guiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

8.  Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia.

Authors:  Shibley Rahman; Trevor W Robbins; John R Hodges; Mitul A Mehta; Peter J Nestor; Luke Clark; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

Review 9.  Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative disease.

Authors:  Tomohiro Omura; Masayuki Kaneko; Yasunobu Okuma; Kazuo Matsubara; Yasuyuki Nomura
Journal:  Oxid Med Cell Longev       Date:  2013-04-18       Impact factor: 6.543
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.